Weyer Christian 4
4 · INTERCEPT PHARMACEUTICALS, INC. · Filed Jan 3, 2020
Insider Transaction Report
Form 4
Weyer Christian
EVP Research and Development
Transactions
- Tax Payment
Common Stock
2019-12-31$123.92/sh−364$45,107→ 13,814 total - Tax Payment
Common Stock
2020-01-01$123.92/sh−54$6,692→ 13,760 total
Footnotes (1)
- [F1]Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of a restricted stock unit award previously granted to the reporting person.